← Open Payments lookup

SUSAN AUSTIN: Open Payments

NPI 1528777927 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$438 in 20 payments from 11 companies in 2025. Trend: 2023 $1,036 · 2024 $1,417 · 2025 $438

Food & beverage: $438
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.7$175
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$60
Corium, LLC2$44
Lundbeck LLC1$27
Bausch Health US, LLC1$24
Otsuka America Pharmaceutical, Inc.1$23
Alkermes, Inc.1$19
ABBVIE INC.1$19
Supernus Pharmaceuticals, Inc.1$17
Takeda Pharmaceuticals U.S.A., Inc.1$15

Products named: FANAPT, CAPLYTA, REXULTI, Azstarys, APLENZIN, ARISTADA, VRAYLAR, Qelbree.

Industry payments across TX — which companies pay providers there.